MARKET

ABSI

ABSI

AbSci Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

11.31
-0.15
-1.31%
After Hours: 11.31 0 0.00% 16:00 09/24 EDT
OPEN
11.26
PREV CLOSE
11.46
HIGH
11.55
LOW
11.08
VOLUME
229.21K
TURNOVER
--
52 WEEK HIGH
31.53
52 WEEK LOW
10.18
MARKET CAP
1.05B
P/E (TTM)
-21.4692
1D
5D
1M
3M
1Y
5Y
Barrack, Rodos & Bacine Notice To Investors in ABSCI Corporation (NASDAQ:ABSI) of Investigation of ABSI
PHILADELPHIA, PA / ACCESSWIRE / September 22, 2021 / Barrack, Rodos & Bacine wishes to notify investors who have sustained losses in ABSCI Corporation ("ABSI" or the Company) that it is investigating possible securities law violations in connection with th...
ACCESSWIRE · 3d ago
Absci to Participate in the BofA Securities 2021 Tech Solutions for Drug Discovery Conference
VANCOUVER, Wash., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be...
GlobeNewswire · 09/13 20:05
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Absci Corporation (ABSI) Investigation
NEW YORK, NY / ACCESSWIRE / September 9, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Absci Corporation ("Absci" or the "Company") (NYSE:ABSI). Investors who purchased Absci sharesare encouraged to ...
ACCESSWIRE · 09/09 18:05
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8)
Benzinga · 09/09 12:17
GSAT, ATER and PXLW among mid-day movers
Gainers: Kadmon (NASDAQ:KDMN) +73%. ICU Medical (NASDAQ:ICUI) +32%. Candel Therapeutics (NASDAQ:CADL) +23%. Globalstar (NYSE:GSAT) +22%. Spectrum Brands (NYSE:SPB) +20%. Vinco Ventures (NASDAQ:BBIG) +19%. WISeKey (NASDAQ:WKEY) +14%. SilverBow (NYSE:SBOW) +...
Seekingalpha · 09/08 17:29
72 Biggest Movers From Yesterday
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.
Benzinga · 09/08 08:57
BRIEF-Absci Reports Quarterly Loss Per Share $2.39
reuters.com · 09/07 13:54
Absci Reports Second Quarter 2021 Financial and Operating Results
VANCOUVER, Wash., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins, today reported financial and operat...
GlobeNewswire · 09/07 12:30
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ABSI. Analyze the recent business situations of AbSci Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ABSI stock price target is 29.00 with a high estimate of 39.00 and a low estimate of 21.00.
EPS
Institutional Holdings
Institutions: 0
Institutional Holdings: 0
% Owned: 0.00%
Shares Outstanding: 92.56M
TypeInstitutionsShares
Increased
0
0
New
0
0
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.13%
Pharmaceuticals & Medical Research
-1.02%
Key Executives
Chief Executive Officer/Founder/Director
Sean McClain
Chief Financial Officer/Primary Contact
Greg Schiffman
Chief Operating Officer
Andreas Pihl
Chief Technology Officer
Matthew Weinstock
General Counsel
Sarah Korman
General Counsel
Lare McClure
Executive Officer
Nikhil Goel
Director
Zachariah Jonasson
No Data
About ABSI
Absci Corporation, formerly AbSci LLC, is a synthetic biology company. The Company with its artificial intelligence (AI)-powered integrated drug creation platform enables the creation of protein-based drugs (biologics) by unifying biologic drug discovery and cell line development processes into one process. It uses synthetic biology technologies and deep learning AI to predict, identify, design, construct, screen, select and scale production of biologic drug candidates, and learn from the data it generates. The Company has drug candidates in approximately nine active programs, eight of the active programs are focused on developing production cell lines for drug candidates. It has one discovery program, focused on lead optimization with Astellas. Its active programs include Bispecific mAb, Bispecific T-cell engager, Cytokine, Fab, Multivalent Fc-fusion, Plasma protein and mAb.

Webull offers kinds of Absci Corp stock information, including NASDAQ:ABSI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABSI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABSI stock methods without spending real money on the virtual paper trading platform.